313 related articles for article (PubMed ID: 37376569)
1. Complement Activation-Independent Attenuation of SARS-CoV-2 Infection by C1q and C4b-Binding Protein.
Beirag N; Varghese PM; Neto MM; Al Aiyan A; Khan HA; Qablan M; Shamji MH; Sim RB; Temperton N; Kishore U
Viruses; 2023 May; 15(6):. PubMed ID: 37376569
[TBL] [Abstract][Full Text] [Related]
2. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
Front Immunol; 2022; 13():960733. PubMed ID: 35967323
[TBL] [Abstract][Full Text] [Related]
3. Human C1q Regulates Influenza A Virus Infection and Inflammatory Response via Its Globular Domain.
Varghese PM; Kishore U; Rajkumari R
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328462
[TBL] [Abstract][Full Text] [Related]
4. Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses.
Paidi RK; Jana M; Mishra RK; Dutta D; Pahan K
J Immunol; 2021 Nov; 207(10):2521-2533. PubMed ID: 34645689
[TBL] [Abstract][Full Text] [Related]
5. C4b Binding Protein Acts as an Innate Immune Effector Against Influenza A Virus.
Varghese PM; Murugaiah V; Beirag N; Temperton N; Khan HA; Alrokayan SH; Al-Ahdal MN; Nal B; Al-Mohanna FA; Sim RB; Kishore U
Front Immunol; 2020; 11():585361. PubMed ID: 33488586
[TBL] [Abstract][Full Text] [Related]
6. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
Khaddaj-Mallat R; Aldib N; Bernard M; Paquette AS; Ferreira A; Lecordier S; Saghatelyan A; Flamand L; ElAli A
Neurobiol Dis; 2021 Dec; 161():105561. PubMed ID: 34780863
[TBL] [Abstract][Full Text] [Related]
8. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19.
Kar P; Saleh-E-In MM; Jaishee N; Anandraj A; Kormuth E; Vellingiri B; Angione C; Rahman PKSM; Pillay S; Sen A; Naidoo D; Roy A; Choi YE
J Cell Biochem; 2022 May; 123(5):964-986. PubMed ID: 35342986
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 attachment to host cells is possibly mediated via RGD-integrin interaction in a calcium-dependent manner and suggests pulmonary EDTA chelation therapy as a novel treatment for COVID 19.
Dakal TC
Immunobiology; 2021 Jan; 226(1):152021. PubMed ID: 33232865
[TBL] [Abstract][Full Text] [Related]
10. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
11. Local Complement Contributes to Pathogenic Activation of Lung Endothelial Cells in SARS-CoV-2 Infection.
Zhang H; Gerasimovskaya E; McCarthy MK; May NA; Prasad RR; Riddle S; McKeon BA; Kumar S; Li M; Hu CJ; Frid MG; Morrison TE; Stenmark KR
Am J Respir Cell Mol Biol; 2023 Aug; 69(2):210-219. PubMed ID: 37071849
[TBL] [Abstract][Full Text] [Related]
12. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.
Borkotoky S; Dey D; Hazarika Z
Mol Biol Rep; 2023 Mar; 50(3):2713-2721. PubMed ID: 36562937
[TBL] [Abstract][Full Text] [Related]
13. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.
Ali YM; Ferrari M; Lynch NJ; Yaseen S; Dudler T; Gragerov S; Demopulos G; Heeney JL; Schwaeble WJ
Front Immunol; 2021; 12():714511. PubMed ID: 34290717
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Proinflammatory Molecules and Tissue Factor by SARS-CoV-2 Spike Protein in Human Placental Cells: Implications for SARS-CoV-2 Pathogenesis in Pregnant Women.
Guo X; Semerci N; De Assis V; Kayisli UA; Schatz F; Steffensen TS; Guzeloglu-Kayisli O; Lockwood CJ
Front Immunol; 2022; 13():876555. PubMed ID: 35464466
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
[TBL] [Abstract][Full Text] [Related]
16. Human pentraxin 3 binds to the complement regulator c4b-binding protein.
Braunschweig A; Józsi M
PLoS One; 2011; 6(8):e23991. PubMed ID: 21915248
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Spike Protein Activates Human Lung Macrophages.
Palestra F; Poto R; Ciardi R; Opromolla G; Secondo A; Tedeschi V; Ferrara AL; Di Crescenzo RM; Galdiero MR; Cristinziano L; Modestino L; Marone G; Fiorelli A; Varricchi G; Loffredo S
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769357
[TBL] [Abstract][Full Text] [Related]
18. Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of C4b-binding protein.
Sjöberg AP; Trouw LA; McGrath FD; Hack CE; Blom AM
J Immunol; 2006 Jun; 176(12):7612-20. PubMed ID: 16751408
[TBL] [Abstract][Full Text] [Related]
19. Studies on the interactions between C-reactive protein and complement proteins.
Bíró A; Rovó Z; Papp D; Cervenak L; Varga L; Füst G; Thielens NM; Arlaud GJ; Prohászka Z
Immunology; 2007 May; 121(1):40-50. PubMed ID: 17244159
[TBL] [Abstract][Full Text] [Related]
20. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.
Chang CW; Parsi KM; Somasundaran M; Vanderleeden E; Liu P; Cruz J; Cousineau A; Finberg RW; Kurt-Jones EA
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
